The price of RAPT Therapeutics Inc (NASDAQ: RAPT) closed at $8.47 in the last session, up 0.71% from day before closing price of $8.41. In other words, the price has increased by $+0.06 from its previous closing price. On the day, 1795334 shares were traded. RAPT stock price reached its highest trading level at $8.74 during the session, while it also had its lowest trading level at $8.31.
Ratios:
We take a closer look at RAPT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 7.41 and its Current Ratio is at 7.41. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, UBS on February 22, 2024, Downgraded its rating to Neutral and sets its target price to $10 from $61 previously.
On February 21, 2024, Leerink Partners Downgraded its rating to Market Perform which previously was Outperform and also lowered its target price recommendation from $42 to $10.
JP Morgan Downgraded its Overweight to Neutral on February 21, 2024, whereas the target price for the stock was revised from $35 to $15.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 05 ’24 when Brockstedt Dirk G. sold 898 shares for $22.78 per share. The transaction valued at 20,456 led to the insider holds 27,820 shares of the business.
HO WILLIAM sold 2,500 shares of RAPT for $54,200 on Dec 21 ’23. The Chief Medical Officer now owns 15,020 shares after completing the transaction at $21.68 per share. On Nov 28 ’23, another insider, HO WILLIAM, who serves as the Chief Medical Officer of the company, sold 1,500 shares for $13.72 each. As a result, the insider received 20,580 and left with 17,520 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RAPT now has a Market Capitalization of 295.08M and an Enterprise Value of 143.13M. Its current Enterprise Value per Revenue stands at 677.37 whereas that against EBITDA is -1.14.
Stock Price History:
Over the past 52 weeks, RAPT has reached a high of $27.35, while it has fallen to a 52-week low of $6.86. The 50-Day Moving Average of the stock is 18.71, while the 200-Day Moving Average is calculated to be 18.48.
Shares Statistics:
According to the various share statistics, RAPT traded on average about 1.20M shares per day over the past 3-months and 1.33M shares per day over the past 10 days. A total of 34.40M shares are outstanding, with a floating share count of 30.59M. Insiders hold about 12.10% of the company’s shares, while institutions hold 90.66% stake in the company. Shares short for RAPT as of Feb 29, 2024 were 2.49M with a Short Ratio of 2.07, compared to 3.95M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 7.23% and a Short% of Float of 9.80%.
Earnings Estimates
The company has 6 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.8 for the current quarter, with a high estimate of -$0.72 and a low estimate of -$0.88, while EPS last year was -$0.76. The consensus estimate for the next quarter is -$0.82, with high estimates of -$0.68 and low estimates of -$0.88.
Analysts are recommending an EPS of between -$2.78 and -$3.51 for the fiscal current year, implying an average EPS of -$3.26. EPS for the following year is -$2.9, with 5 analysts recommending between -$2.28 and -$3.69.
